Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.45 |
| ▸ | CTSS | P25774 | 4/20 | 0.44 |
| ▸ | CTSK | P43235 | 4/20 | 0.44 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.44 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.37 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17258271 | 1.00 | AAK1 (0.45) | AAK1CTSSCTSKROCK1PRMT5 | |
| SCHEMBL25528857 | 1.00 | AAK1 (0.45) | AAK1CTSSCTSKROCK1PRMT5 | |
| SCHEMBL17002747 | 0.92 | CTSS (0.46) | AAK1CTSSCTSKROCK1PRMT5 | |
| SCHEMBL21732909 | 0.89 | AAK1 (0.46) | AAK1CTSSCTSKROCK1PRMT5 | |
| SCHEMBL21732896 | 0.89 | AAK1 (0.46) | AAK1CTSSCTSKROCK1PRMT5 | |
| SCHEMBL23521565 | 0.89 | AAK1 (0.46) | AAK1CTSSCTSKROCK1PRMT5 | |
| SCHEMBL17258280 | 0.88 | AAK1 (0.45) | AAK1CTSSCTSKPRMT5WDR77 | |
| SCHEMBL17258259 | 0.88 | AAK1 (0.45) | AAK1CTSSCTSKPRMT5WDR77 | |
| SCHEMBL17258257 | 0.88 | AAK1 (0.45) | AAK1CTSSCTSKPRMT5WDR77 | |
| SCHEMBL17258277 | 0.88 | AAK1 (0.45) | AAK1CTSSCTSKPRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150329564-A1 | CHIRAL 4-BORONOPHENYLALANINE (BPA) DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 18F-LABELED BPA USING SAID DERIVATIVE | OSAKA PREFECTURE UNIVERSITY PUBLIC CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150329564-A1 | CHIRAL 4-BORONOPHENYLALANINE (BPA) DERIVATIVE AND METHOD FOR PRODUCING SAME, AND METHOD FOR PRODUCING 18F-LABELED BPA USING SAID DERIVATIVE | FFAR3, BRS3, FSHR | AAK1 2294/4885CTSS 4468/4885CTSK 4360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.